Quality Standards For Heparin Further Strengthened
5/25/2012
To help further secure a safe supply of the widely-used blood thinner heparin, a third round of revisions to quality standards for the drug has been advanced by the U.S. Pharmacopeial Convention (USP). USP's Expert Panel on Unfractionated Heparin ended a two-day meeting on May 16th, 2012, and recommended finalization of the proposed changes...
Mutation Found In Half Of All Prostate Cancers May Lead To Disease Development And Other Cancers
5/24/2012
Up to half of all prostate cancer cells have a chromosomal rearrangement that results in a new "fusion" gene and formation of its unique protein - but no one has known how that alteration promotes cancer growth...
Potential Benefits Of Novel Leukemia Treatment
5/24/2012
Scientists at Virginia Commonwealth University Massey Cancer Center may be one step closer to developing a new therapy for acute myeloid leukemia (AML) after discovering that the targeted agents obatoclax and sorafenib kill leukemia cells much more effectively when combined than when the drugs are administered individually...
New Drug To Fight Against Localized High-Risk Prostate Tumors
5/24/2012
Men with prostate cancer could significantly benefit from a recently approved hormone-depleting drug, according to results from a phase II clinical trial. The drug - abiraterone acetate (Zytiga(R)) - can help eliminate or almost eliminate tumors in many prostate cancer patients whose cancer has not yet metastasized...
Early-Life Risk Factors For Non-Hodgkin Lymphoma
5/24/2012
Factors influencing early life non-Hodgkin lymphoma (NHL) incidence include family characteristics, high fetal growth, older maternal age, low birth order, and male gender, according to a study published in the Journal of the National Cancer Institute...
Protection Against Childhood Cancers May Be Provided By Folic Acid Fortification
5/24/2012
Researchers from the University of Minnesota and Washington University in St. Louis have found folic acid fortification of grain products in the United States may have an impact on lowering some childhood cancers...
Innovative Computer Modeling Techniques Enable Creation Of New Anti-Cancer Drug
5/24/2012
A team of University of Hawaii Cancer Center scientists led by James Turkson, Ph.D. have created a new type of anti-cancer drug named BP-1-102. The drug, which can be orally administered, targets a key protein that triggers the development of many types of cancer including lung, breast and skin cancers...
Children With Big-Bone Fractures Rarely Require Anti-Clotting Drugs
5/24/2012
Children with pelvic and thigh fractures develop dangerous blood clots so rarely that anti-clotting therapy should be given only to those with underlying conditions that increase clotting risk, according to a study from Johns Hopkins Children's Center...
Non-Hodgkin Lymphoma Risk Factors During Early Life
5/23/2012
Older maternal age, low birth order, male gender, family characteristics, and high fetal growth are all factors that increase the risk of developing early life non-Hodgkin lymphoma (NHL), say researchers. According to the study, published in the Journal of National Cancer Institute, the incidence of NHL has increased significantly over the last 5 decades...
Elderly Lung Cancer Patients May Live Longer With Chemotherapy And Radiation Together
5/23/2012
Elderly patients with inoperable non-small-cell lung cancer (NSCLC) who take a daily dose of carboplatin (a chemotherapy drug), in addition to radiotherapy, live significantly longer than those who receive radiotherapy alone, say Japanese researchers. The study is published Online First in The Lancet Oncology...